The results reported here strongly suggest that the TK 210 ELISA is able to detect a significant differences in the levels of the TK1 protein in sera from breast cancer patients in the T1, T2, and T3 stages compared to healthy. This evidence concerns the gene TK1 and breast carcinoma.